As of 2026-04-23, the Fair Value of Novocure Ltd (NVCR) is -5.99 USD. This value is based on the Peter Lynch's Fair Value formula. With the current market price of 13.02 USD, the upside of Novocure Ltd is -145.97%.
With the market price of 13.02 USD and our fair value calculation, Novocure Ltd (NVCR) is not a good investment. Investing in Novocure stocks now will result in a potential loss of 145.97%.
Note: valuation result may not be accurate due to the company's negative EPS.
Peter Lynch's formula is:
The earnings growth rate we use in the formula is the average growth rate of net income/earnings over the last 5 years. If the average growth rate is smaller than 5%, we set it to 5%. If it is larger than 25%, we set it to 25%. If the TTM EPS is negative, Peter Lynch Fair Value's result can be unreliable.
| Historical Earnings | ||||||
| 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2025-12-31 | 5Y Avg | |
| Net income | -58.40 | -92.50 | -207.04 | -168.63 | -136.23 | -132.56 |
| YoY growth | -394.95% | -58.39% | -123.83% | 18.55% | 19.21% | -107.88% |
| Market Cap (mil) | 1,481.55 |
| P/E | |
| Forward P/E |
| EPS | -1.20 |
| Avg earnings growth rate | -107.88% |
| TTM earnings | -136.23 |